Antiretroviral Therapy for HIV-2 Infection in Senegal

塞内加尔针对 HIV-2 感染的抗逆转录病毒治疗

• 批准号: 7367162
• 负责人: Geoffrey Scott Gottlieb
• 金额: $ 62.92万
• 依托单位: UNIVERSITY OF WASHINGTON
• 依托单位国家: 美国
• 财政年份: 2005
• 资助国家: 美国
• 起止时间: 2005-06-07 至 2010-02-28
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/7367162
• 关键词: Acquired Immunodeficiency Syndrome; Adverse effects; Anti-Retroviral Agents; Arts; Blood; CD3 Antigens; CD4 Positive T Lymphocytes; CD4/CD8 ratio procedure; CD8B1 gene; Cell Count; Cessation of life; Characteristics; Clinical; Control Groups; Cultured Cells; Drug resistance; Drug-sensitive; Event; Evolution; Failure; Gagging; Goals; Growth; HIV-1; HIV-1 drug resistance; HIV-2; Immunologics; Individual; Infection; Mediating; Methods; Mutation; NNRTI-resistance; Natural History; Outcome; Pattern; Peripheral Blood Mononuclear Cell; Phenotype; Phylogenetic Analysis; Plasma; Play; Population; Protease Gene; RNA; RNA-Directed DNA Polymerase; Rate; Resistance; Resources; Role; Senegal; Sexual Transmission; Staging; Symptoms; T-Lymphocyte Subsets; Testing; Time; Treatment Protocols; Vertical Disease Transmission; Viral; Viral Load result; Virus; antiretroviral therapy; cohort; drug resistant virus; env Genes; fitness; mortality; programs; prospective; response; trend; viral DNA

DESCRIPTION (provided by applicant): The overarching goals of this proposal are to further our understanding of the effect of potent antiretroviral therapy (ART) on Human Immunodeficiency Virus Type 2 (HIV-2) infection. HIV-2 is generally less pathogenic than HIV-1. Compared to HIV-1, HIV-2 infection is characterized by a much longer asymptomatic stage, lower plasma viral loads, slower decline in CD4+ T cell count, decreased mortality rate due to AIDS, lower rates of mother to child transmission, and lower rates of sexual transmission. Nonetheless, a significant proportion of HIV-2 infected individuals eventually progress to AIDS. Antiretrov'iral therapy is becoming increasingly available in resource-limited settings. In Senegal where both HIV-1 and HIV-2 are found, a national program of providing antiretroviral treatment (ART) for those with AIDS, CD4+ T cell counts less than 200/mm3, or CD4+ T cell counts less than 350/mm3 and clinical symptoms has been established. However, the effects of ART on outcome, immunologic response, viral load, dynamics and evolution, HIV-2 drug resistance and fitness in HIV-2 infected individuals are largely unknown. Our longstanding longitudinal cohort of HIV-2 infected subjects from Dakar, Senegal provides a unique opportunity to study the role ART plays in suppressing HIV-2 infection. The Specific Aims of this proposal are: AIM 1: To determine the clinical, virologic and immunologic outcomes associated with antiretroviral therapy (ART) in a longitudinal prospective HIV-2 infected Senegalese cohort. AIM 2: To assess role of drug resistance in viruses that emerge in HIV-2 infected subjects with virologic failure and to determine if there are qualitative and quantitative differences the drug resistant viruses that emerge between HIV-2 and HIV-1.

描述（由申请人提供）：本提案的总体目标是进一步了解强效抗逆转录病毒疗法（ART）对人类免疫缺陷病毒2型（HIV-2）感染的影响。HIV-2的致病性通常低于HIV-1。与HIV-1相比，HIV-2感染的特点是无症状期更长，血浆病毒载量更低，CD 4 + T细胞计数下降较慢，艾滋病死亡率降低，母婴传播率降低，性传播率降低。尽管如此，仍有相当比例的HIV-2感染者最终发展为艾滋病。抗逆转录病毒疗法在资源有限的环境中变得越来越可用。在发现HIV-1和HIV-2的塞内加尔，已经制定了一项国家方案，为那些患有艾滋病、CD 4 + T细胞计数低于200/mm 3或CD 4 + T细胞计数低于350/mm 3并有临床症状的人提供抗逆转录病毒治疗。 然而，ART对HIV-2感染者的结局、免疫应答、病毒载量、动力学和进化、HIV-2耐药性和适应性的影响在很大程度上是未知的。我们来自塞内加尔达喀尔的HIV-2感染受试者的长期纵向队列提供了一个独特的机会来研究ART在抑制HIV-2感染中的作用。该提案的具体目标是：目标1：确定在纵向前瞻性HIV-2感染的塞内加尔队列中与抗逆转录病毒治疗（ART）相关的临床、病毒学和免疫学结局。目标2：评估耐药性在病毒学失败的HIV-2感染受试者中出现的病毒中的作用，并确定HIV-2和HIV-1之间出现的耐药性病毒是否存在定性和定量差异。